On June 24, 2012, the U.S. Supreme Court handed down its decision in Mutual Pharmaceutical Co. Inc. v. Bartlett, 570 U.S.
The U.S. Supreme Court’s decision in Mutual Pharmaceutical Co., Inc. v. Bartlett, No. 12-142, decided June 24, 2013, may assist defense counsel in defending product liability cases involving FIFRA-regulated products such as herbicides and pesticides.
On June 13, the Supreme Court of Alabama issued an order announcing that it will revisit a controversial January ruling, in which the court held that a name-branded drug maker may be held liable, under Alabama law, for injuries caused by a generic version of its drug, manufactured and distributed by a different company.
Karen Bartlett took a generic drug called sulindac that her doctor prescribed to her for shoulder pain. About three weeks later, her skin began to peel off due to a reaction to the drug. She is now left with burn-like lesions over two-thirds of her body and she is nearly blind. She spent months in a burn unit in a medically induced coma.
Big Pharma just keeps getting bigger and bigger, while the FDA grows more and more incompetent. Drug lobbyists have a powerful hold on our government and I don’t imagine that will change any time soon.